FDA Approves Wegovy (Semaglutide) for Obesity in Teens 12 and Up

FDA approves semaglutide 2.4mg (Wegovy), a once-weekly subcutaneous injection, for treating obesity in adolescents aged 12 years and older.

Tuesday, January 3, 2023 at 3:01 pm